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Age-related macular degeneration (AMD) represents the most common cause of
blindness in the elderly in the Western world. An impairment of the outer blood-retina
barrier and a localized inflammatory microenvironment cause sprouting of choroidal
neovascular membranes (CNV) in neovascular AMD that are in intimate contact with
surrounding myeloid cells, such as retinal microglia, and ultimately lead to visual
impairment. The discovery of novel target molecules to interfere with angiogenesis
and inflammation is vital for future treatment approaches in AMD patients. To explore
the transcriptional profile and the function of retinal microglia at sites of CNV, we
performed a comprehensive RNA-seq analysis of retinal microglia in the mouse model of
laser-induced choroidal neovascularization (mCNV). Here, we identified the angiogenic
factor Osteopontin (Opn), also known as “secreted phosphoprotein 1” (Spp1), as one of
the most highly expressed genes in retinal microglia in the course of CNV formation.
We confirmed the presence of SPP1 at the lesion site in recruited retinal microglia
in Cx3cr1CreER:Rosa26-tdTomato reporter mice by confocal microscopy and in whole
retinal tissue lysates by ELISA highlighting a massive local production of SPP1. Inhibition
of SPP1 by intravitreal injection of an anti-SPP1 antibody significantly increased the
lesion size compared to IgG-treated control eyes. In line with our results in rodents, we
found an increased SPP1 mRNA expression in surgically extracted human choroidal
neovascular (hCNV) membranes by the quantitative RNA-seq approach of massive
analysis of cDNA ends (MACE). Numerous IBA1+SPP1+ myeloid cells were detected
in human CNV membranes. Taken together, these results highlight the importance of
SPP1 in the formation of CNV and potentially offer new opportunities for therapeutic
intervention by modulating the SPP1 pathway.
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HIGHLIGHTS
- Spp1 emerges as one of the top differentially regulated
angiogenic genes in murine microglia in the model of laser-
induced CNV.
- SPP1 protein expression is highly increased in CNV tissue and
present in retinal microglia.
- Scavenging of SPP1 by an anti-SPP1 antibody leads to
increased lesion size in CNV.
- SPP1 expression is highly induced in surgically extracted
human choroidal neovascularization membranes on both
RNA and protein levels.
INTRODUCTION
Microglia represent the resident tissue-macrophages of the retina
and the brain and originate from the extra-embryonic yolk
sac early during development (Ginhoux et al., 2010; Kierdorf
et al., 2013; Goldmann et al., 2016; O’Koren et al., 2019;
Wieghofer et al., in press). In the context of neurodegeneration,
neuroinflammation, or other insults, the composition as well as
the gene and protein expression signatures of myeloid cells can
dramatically change (Ajami et al., 2018; O’Koren et al., 2019;
Wieghofer et al., in press). These changes include microglia
activation leading to relevant functional alterations. The mode of
action can thereby be beneficial but also detrimental depending
on the disease model affecting microglia in the brain or retina
(Reyes et al., 2017; Masuda et al., 2020).
Choroidal neovascularisation (CNV) is a common cause of
irreversible vision loss in patients with age-related macular
degeneration (AMD), which is the leading cause of blindness in
the elderly (Fine et al., 2000). In a previous study, we showed
that myeloid cells represent a heterogeneous cell population that
accumulates at sites of CNV and modulates its formation in a
laser-induced CNV mouse model, which is a widely used model
for nAMD (Lambert et al., 2013; Wieghofer et al., in press). The
close interplay between myeloid cells and blood vessel formation
has been extensively studied in the past; however, the origin
of accumulating myeloid cells in this model has long remained
unclear (Oh et al., 1999; Fantin et al., 2010; Dejda et al., 2016;
Usui-Ouchi et al., 2020). Recently we have shown that retinal
microglia are the dominant innate immune cell population
at sites of CNV and are characterized by a specific disease-
associated gene expression signature similar to other disease
models, including Spp1 encoding the secreted phosphoprotein
1 (SPP1), Lgals3 (lectin, galactose binding, soluble 3), and Apoe
(Apolipoprotein E) (Keren-Shaul et al., 2017; O’Koren et al.,
2019; Wieghofer et al., in press). In particular, the role of
secreted SPP1 in vascular diseases and its potential to serve as
an easily accessible biomarker present in blood serum and other
body fluids has gained attention recently (Lok and Lyle, 2019).
SPP1 is a multifaceted protein involved in homeostatic functions
and pathophysiological processes like bone morphogenesis,
vascular remodeling, recruitment of leukocytes, cell adhesion,
and extracellullar matrix remodeling (Lok and Lyle, 2019). The
broad spectrum of features is reflected by the cell types expressing
SPP1 including leukocytes, epithelial and endothelial cells, and
neurons in humans (Kunii et al., 2009).
As a matricellular cytokine SPP1 binds to integrin receptors,
like αV integrins, and certain splice variants of the hyaluronic
acid receptor CD44, which are expressed by endothelial cells
(Lok and Lyle, 2019). The angiogenic capacity combined with its
potential to shape myeloid cell recruitment highlights SPP1 as a
promising target in vascular diseases (Yu et al., 2017; Lok and
Lyle, 2019).
The goal of our study was to explore gene expression
signatures of native and CNV-associated retinal microglia by
comprehensive bulk RNA-seq. Furthermore, we investigated the
role of SPP1 in CNV formation by local intraocular application
of an antibody directed against SPP1. Finally, we correlated our
findings in mice to human CNV samples from nAMD patients.
Our results underline the importance of SPP1 in the formation
of CNV in mice and humans, thus paving the way for new
therapeutic interventions by modulating the SPP1 pathway.
RESULTS
Identification of the Angiogenic Spp1 Gene
in Experimental Choroidal
Neovascularization
To gain more insight into the transcriptional profile and
angiogenic capacity of microglia during development
of experimental choroidal neovascularization, we
conducted bulk RNA-seq of flow cytometry-isolated
CD45loCD11b+CX3CR1
+Ly6C−Ly6G− retinal microglia at
CNV d3 (Figure 1A). The principal component analysis clearly
showed distinct gene expression patterns between the lasered
group 3 days after experimental laser treatment and unlasered
control mice (Figure 1B). Next, we determined the differentially
expressed genes (DEG) between CNV-associated MG and
control microglia and found that 654 DEG were significantly
increased in microglia in association with CNV formation.
Among the top five DEG increased in CNV-associated MG
were Fn1 (log2FC = 9.8, padj. = 2.9 × 10−15), Spp1 (log2FC
= 6.6, padj = 3.8 × 10−25), Ifi27I2a (log2FC = 2.9, padj =
7.7 × 10−8), Cd74 (log2FC = 2.7, padj = 7.9 × 10−7), and
Cd72 (log2FC= 2.4, padj = 2.2 × 10−24) (Figures 1C,D). Also
Apoe (log2FC = 1.7, padj = 3.3 × 10−12) was significantly
upregulated and is an important regulator for the transition
into disease-associated microglia (Song and Colonna, 2018). In
addition, genes typically expressed by antigen-presenting cells,
such as H2-Ab1 (log2FC = 2.1, padj = 9.3 × 10−6) and Cd74, or
involved in interferon signaling, like Ifitm3 (log2FC = 1.59, padj
= 0.005) and Ifi27I2a,were present among the upregulated genes
in CNV (Figures 1C,D). To identify functionally associated
genes, we performed a gene ontology (GO) analysis and
found genes relevant for the biological processes “myeloid
leukocyte migration,” “extracellular matrix binding,” and “tissue
remodeling” (Figure 1E). These genes include Ccl2 (log2FC
= 2.5, padj = 4.2 × 10−7) encoding a chemokine attracting
peripheral blood monocytes and Lgals3 (log2FC = 3.1, padj
= 8.2 × 10−10) that has been described in disease-associated
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FIGURE 1 | Expression of secreted phosphoprotein 1 increases upon experimental induction of choroidal neovascularization in mice. (A) Experimental scheme
depicting the workflow for isolation of viable and single CD45loCD11b+CX3CR1
+Ly6C−Ly6G− cells from the retina under healthy conditions and experimental
choroidal neovascularization at d3 after induction for unbiased RNA-seq. Six focal argon laser burns were applied to each retina to induce microglia activation and
subsequent choroidal neovascularization formation in mice (mCNV). (B) Principal component analysis of transcripts analyzed by RNA-seq. (C) Scatter plot using the
log2 transformation of normalized counts visualizing differentially expressed genes between healthy conditions (y-axis) and experimental choroidal neovascularization
on d3 after laser treatment (x-axis). The top 10 highest expressed genes are labeled. Definition of differentially expressed genes: abs(log2FC) > 1.5 & padjusted <
0.05. (D) Heatmap of the top 10 differentially expressed genes between healthy conditions and experimental choroidal neovascularization on d3 after laser treatment
according to the mean expression in the laser group. The z-score represents the gene expression in relation to its mean expression by standard deviation units (red:
upregulation, blue: downregulation). (E) Box plots illustrating the top five factors of the most disease-relevant GO terms ordered according to the mean expression in
the laser group.
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microglia and is responsible for interaction with the extracellular
matrix (O’Koren et al., 2019; Boeck et al., 2020) (Figure 1D).
Nevertheless, besides its known role in angiogenesis, Spp1 was
also the most highly expressed gene within all three biological
processes GO terms, which prompted us to investigate its role in
further detail (Figure 1E).
Validation and Interference With SPP1 on
the Protein Level in CNV Mice
To validate the expression of SPP1 protein we used conditional
Cx3cr1CreER:Rosa26-tdTomato reporter mice to specifically
label microglia in the CNV model (Goldmann et al., 2013;
Wieghofer et al., 2015, in press). Eight weeks after Tamoxifen
treatment to induce Tomato expression in retinal microglia,
mice were laser-treated to induce CNV (d0) and sacrificed 3
days later for immunofluorescent staining and confocal imaging
(Figures 2A,B). Here, we found numerous Tomato+ microglia
cells expressing SPP1 and exhibiting an amoeboid appearance,
which indicates an activated phenotype in contrast to their
ramified state under homeostatic conditions (Figure 2B).
Tomato−SPP1+ cells were present indicating that other cell
types than microglia are also involved in CNV formation. In
accordance with our RNA-seq data, a strong increase of SPP1
protein in whole CNV tissue was detectable by ELISA (CNV:
62.30 ± 6.90, control: 6.00 ± 2.03, p < 0.0001) (Figure 2C).
These findings prompted us to inhibit SPP1 in the course of
CNV development by an intravitreal administration of an
anti-SPP1 antibody 1 day after CNV laser-induction. The
contralateral eyes were treated with an IgG control (Figure 2D).
The increase in lesion size was clearly visible over time by
funduscopic imaging and showed severely enhanced vascular
leakage under anti-SPP1 treatment visualized by angiography
(Figure 2E). The quantification of the lesion size based on
Collagen IV immunoreactivity revealed a more than 2-fold
increase of the lesioned area (2.25 ± 1.05, p = 0.0004) in eyes
treated with anti-SPP1 compared to IgG controls. Consequently,
the intraocular application of anti-SPP1 antibodies suggested
a protective, anti-angiogenic function of SPP1 during CNV
formation (Figure 2E).
SPP1 Expression in Mice Can Be Linked to
Human Neovascular AMD
To generalize our findings, we next explored the expression
of SPP1 in human CNV by conducting a post-hoc analysis
of already available RNA-seq data from surgically extracted
human membranes of choroidal neovascularization (hCNV)
(Figure 3A) (Schlecht et al., 2020). Interestingly, also in human
CNV, SPP1 was one of the most prominent upregulated
angiogenic genes when compared to healthy controls (CNV:
18.41 ± 11.38 reads, controls: 0.70 ± 0.64 reads, padj =
0.019) (Figure 3B). Next, we investigated the expression of SPP1
protein in human body donor tissue as compared to human
CNVmembranes by immunofluorescence (Figure 3C). In retinal
IBA1+ microglia, SPP1 was barely detectable in healthy control
tissue, which is in line with previous studies (Masuda et al., 2019)
(Figure 3C). Only in the choroid, a faint staining for SPP1 was
observed in IBA1+ macrophages, whereas in CNV tissue a strong
expression of SPP1 was detected in IBA1+ cells. Non-myeloid
IBA1−SPP1+ cells were also present at the site of the lesion,
similar to our findings in mice (Figures 2B, 3C). Overall, we
found comparable expression of SPP1 RNA and SPP1 protein in
both murine and human tissue samples, suggesting a functional
relevance of the molecule in CNV formation.
DISCUSSION
Retinal microglia cells are key players in the modulation of
disease course and severity across disease models including
retinal degeneration, diabetic retinopathy, retinal light damage,
and CNV (O’Koren et al., 2019; Van Hove et al., 2020; Wieghofer
et al., in press). The concept of disease-associated microglia
(DAM), initially introduced for brain disease models involving
microglia activation, was recently successfully applied to retinal
microglia (Keren-Shaul et al., 2017; O’Koren et al., 2019;
Wieghofer et al., in press).
Single-cell RNA-seq (scRNA-seq) of fresh tissue samples
is advantageous to characterize subtypes of all kinds of cell
types. However, fresh human CNV tissue is not available as
surgical CNV extraction became obsolete due to novel treatment
strategies and archived samples are not amenable to scRNA-seq
preparation (Masuda et al., 2019, 2020; Schlecht et al., 2020). To
compare gene expression signatures across species, we applied
bulk RNA-seq approaches on experimentally induced murine
and archived human choroidal neovascularization tissue samples.
Gene expression profiling of retinal microglia by RNA-seq
revealed a CNV-associated phenotype clearly distinguishable
from the profile of retinal microglia in untreated control mice.
Significant changes were observed for transcripts functionally
relevant in fibrosis (Fn1), antigen-presentation (Cd74, H2-
Ab1), myeloid cell migration (Cd74, Ccl2, Lgals3), phagocytosis
(Lgals3), and inflammation (Ifi27I2a, Ifitm3, Lgals3). With regard
to antigen presentation, we recently demonstrated that Cd74 is
not expressed in retinal microglia under homeostatic conditions
but induced together with H2-Aa, encoding MHCII, upon CNV
induction, which is in line with the present study (Wieghofer
et al., in press). Of note, the induced expression of MHCII (H2-
Aa) was also confirmed on the protein level inmice and in human
CNV membranes (Wieghofer et al., in press). The observed
increase of Apoe expression further supports the induction of
the DAM gene expression signature mediated by binding to the
triggering receptor of myeloid cells 2 (TREM2), like it was shown
in the brain (Song and Colonna, 2018). Furthermore, Apoe was
highly expressed in DAM in a model of retinal light damage and,
most importantly, in mononuclear phagocytes in the subretinal
space in AMD patients (Levy et al., 2015a,b; O’Koren et al., 2019).
In another study, SPP1 was found to be key for the promotion of
macrophage survival in the subretinal space in the CNV model
(Beguier et al., 2020).
The highly significant induction of Spp1 in retinal microglia
points to this gene as a key mediator of CNV pathology, which
could be functionally associated with three major hallmarks
of the CNV model: angiogenesis, macrophage recruitment,
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FIGURE 2 | Interference with SPP1 on protein level changes the outcome of experimental choroidal neovascularization. (A) Experimental scheme. Six weeks old
Cx3cr1CreER:Rosa26-tdTomato mice were exposed to TAM to induce microglia-specific Tomato labeling. Eight weeks later three focal argon laser burns were applied
to each retina to induce microglia activation and subsequent choroidal neovascularization (mCNV). Mice were sacrificed at CNV d3 for immunofluorescence stainings.
(B) Representative immunofluorescence images for collagen IV (white), Tomato (red), and SPP1 (green) in Cx3cr1CreER:Rosa26-tdTomato mice on d3 after CNV
induction. Arrows point to a Tomato+SPP1+ rMG while asterisks indicate a Tomato+SPP1− rMG. Representative pictures of seven mice out of two independent
experiments are displayed. (C) SPP1 levels in lesioned RPE tissue (mCNV) of wildtype mice compared to untreated controls d3 after CNV induction as measured by
ELISA (control: n = 7, CNV: n = 8 from two independent experiments). Bars represent means ± s.e.m. ***p < 0.0001, Unpaired t-test. (D) Experimental scheme.
Choroidal neovascularization was laser induced at day 0 (d0) in Cx3cr1GFP/+ mice. At d1, 50 ng anti-SPP1 (dissolved in 1 µL PBS injection volume) was injected
intravitreally into one eye and the same amount of IgG control antibody (again dissolved in PBS) into the contralateral eye. Mice were sacrificed at d7 after evaluation
of fundus and fluorescence angiography. (E) Exemplary funduscopic image of lesions directly after laser burn-induced mCNV at day 0 (left) and d7 (right) under
treatment with IgG control (top row) or anti-SPP1 antibody (bottom row). Fluorescence angiography indicates leakage of intraperitoneally applied Fluorescein.
Representative Imaris reconstruction of collagen IV immunoreactivity and corresponding quantification of CNV size in mice that underwent laser treatment and
subsequent injection of either anti-SPP1 into the left eye (squares) or IgG isotype controls into the right eye (circles). Each symbol represents the mean lesion size
within one eye of one mouse, based on Collagen IV area of individual lesions imaged by confocal microscopy and normalized to the IgG control. Corresponding values
from left and right eye are displayed as pairs. Bar graphs represent the overall mean value of seven mice in total. All values were normalized to the IgG control mean
value. Bars represent mean ± s.e.m. ***p < 0.001, ratio paired t-test.
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FIGURE 3 | Quantitative RNA-seq analysis and immunofluorescence reveal the presence of SPP1 in human CNV tissue. (A) Experimental scheme. RNA was
extracted from formalin-fixed and paraffin-embedded human healthy choroid and CNV membranes for massive analysis of cDNA ends (MACE) RNA-seq analysis.
Retinal pigment epithelium is abbreviated with RPE. (B) SPP1 expression was quantified by RNA-seq (MACE) in four control samples and four CNV membranes (p =
0.019). Bars represent mean ± s.e.m. (C) Immunofluorescence for DAPI (white), SPP1 (green), and IBA1 (red) in the retina and RPE/choroid of one body donor and in
a CNV membrane of a patient diagnosed with neovascular age-related macular degeneration. IBA1+SPP1+ macrophages (arrow) could be found in both healthy
RPE/choroid and CNV membranes in line with the RNA-seq (MACE) results, next to IBA1+SPP1− macrophages (asterisk). Arrowheads point to IBA1−SPP1+ cells.
Dashed white squares indicate the region of interest shown as magnifications on the right side. The layering is indicated for the inner and outer plexiform layer (IPL,
OPL), inner and outer nuclear layer (INL, ONL), retinal pigment epithelium (RPE), and choroid.
and tissue remodeling of the extracellular matrix (Tobe et al.,
1998; Lambert et al., 2013). Also in a murine model of light-
induced neurodegeneration, Spp1was highly induced in a specific
microglial cluster that also expressed Lgals1 and Lgals3 as
distinctive marker for subretinal DAM (O’Koren et al., 2019).
In line with previous CNV studies, the lesion size was affected
by varying degrees in Spp1−/− mice or after systemic application
of an antibody directed against SPP1 (Fujita et al., 2011; Ong
et al., 2011; Beguier et al., 2020). In these experiments, which
are based on systemic inhibition of SPP1, CNV size is decreased
(Fujita et al., 2011; Ong et al., 2011), whereas in the current study,
local inhibition of SPP1 by antibodies leads to larger lesions. This
can be explained by several factors. The systemic inhibition of
SPP1 not only leads to smaller lesions but also to severe changes
in the hematopoiesis of myeloid cells in the bone marrow,
which, as previously shown, is reflected by a reduced number
of the monocyte-macrophage dendritic cell progenitors (MDP)
(Magdaleno et al., 2018). A systemic treatment could thereby
alter the overall composition of myeloid cells in the blood, finally
leading to lower numbers of recruited macrophages and smaller
lesions (Fujita et al., 2011). In the clinical routine an antibody
against vascular endothelial growth factor (VEGF) is applied
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intravitreally in patients suffering from neovascular AMD to
achieve high local concentration and reduce the possibility of
side effects. Therefore, we administered anti-SPP1 in a more
specific approach by applying it locally into the eye to minimize
its influence on peripheral immune compartments. In a recent
study, the same antibody was successfully applied in vivo proving
its suitability and bioactivity after intravitreal injection (Beguier
et al., 2020) besides its use in vitro (Hosaka et al., 2017; Hulsmans
et al., 2018). Despite the same mode of application in the CNV
model, anti-SPP1 was only given in combination with other
factors, and the significantly differing treatment regimen with
respect to dosage, time points, and frequency of applications
together with a later time point of analysis after CNV does not
allow a direct comparison (Beguier et al., 2020). In contrast
to previous studies including CNV experiments in constitutive
Spp1−/− mice, we found a more than 2-fold increase in lesion
size at CNV d7 with anti-SPP1 treatment (Ong et al., 2011).
Our findings support a protective function of SPP1 during CNV
development that could be mediated at the level of myeloid cells
but also through other sources of SPP1 (Lok and Lyle, 2019).
Several studies point toward a microglia-related effect. First, this
is supported by the fact that microglia were shown to be the
predominant myeloid cell type at the lesion site (Wieghofer et al.,
in press) and their expression of SPP1 upon CNV induction, as
confirmed on RNA and protein levels. Furthermore, treatment
with SPP1 in vitro revealed functionally relevant changes in
microglia response to external stimuli (Tambuyzer et al., 2012;
Patouraux et al., 2014; Rabenstein et al., 2016). In LPS-stimulated
microglia, the production of pro-inflammatory cytokines, like IL-
6 and TNFα, was significantly reduced under SPP1 treatment,
thereby promoting an anti-inflammatory phenotype (Rabenstein
et al., 2016). In addition, the presence of SPP1 significantly
improved the survival of microglia under stress conditions and
increased the phagocytic activity of microglia in vitro (Tambuyzer
et al., 2012; Rabenstein et al., 2016). A dose-dependent decrease
in superoxide production was found, as well, which is in line
with an increase of iNOS expression upon SPP1 decrease in a
macrophage cell line (Tambuyzer et al., 2012; Patouraux et al.,
2014). In the same study, the authors could reverse the SPP1-
mediated increased proliferation rate of microglia by applying
an anti-OPN antibody in vitro (Tambuyzer et al., 2012), which
resembles our antibody-mediated interference with SPP1 in the
experimental CNV model. Of note, secreted SPP1 stimulates
macrophages to produce CCL2, which was also detected in CNV-
associated retinal microglia and acts as a potent chemokine
for the recruitment of peripheral myeloid cells (Rowe et al.,
2014). These cells could further modulate angiogenesis but
represent only a fraction of the overall myeloid cell composition
dominated by microglia (Wieghofer et al., in press). However, if
the aforementioned in vitro observations in microglial biology
would apply to the in vivo situation, the blockage of SPP1 would
have an escalating effect on the basic functions of microglia, like
pro-inflammatory cytokine and production of reactive oxygen
species, leading to a worsening of tissue damage at the lesion
site. The availability of conditional CreERT2 deleter strains
targeting microglia like the Cx3cr1CreER mouse model opens not
only the possibility to label microglia specifically but also create
conditional knockout mice (Droho et al., 2020; Wieghofer et al.,
in press). This strategy was successfully applied in the past and
will decipher microglial functions in a muchmore specific setting
in the future (Lückoff et al., 2016; Wolf et al., 2020).
Beside the observed role of microglia, we cannot completely
rule out a functionally relevant effect of the anti-SPP1 treatment
on other non-myeloid cells. For example, SPP1 is also expressed
by endothelial and smooth muscle cells and loss of stroma-
derived SPP1 led to enhanced tumor progression in mice
(O’Brien et al., 1994; Szulzewsky et al., 2017). Interestingly, the
interaction of a CD44v6 splice variant, acting as a receptor
for SPP1, with VEGF receptor 2 (VEGFR2) on endothelial
cells suggests an interference with SPP1 signaling across cell
types (Tremmel et al., 2009). Furthermore, our study shows a
considerable expression of SPP1 in human retinal neurons, which
is consistent with findings in rat retina (Chidlow et al., 2008).
Thus, an indirect effect of anti-SPP1 treatment via modulation
of the SPP1 pathway in neurons cannot be excluded. RNA-seq
analysis of whole human CNV membranes revealed SPP1 as one
of the most highly regulated genes within the disease-relevant
GO terms “extracellular structure organization” and “response
to wounding,” similar to our findings in mice (Schlecht et al.,
2020). Our immunofluorescent analysis revealed that SPP1 was
predominantly expressed in IBA1+ mononuclear phagocytes in
human CNV, which strongly resembled the situation present
in the murine experimental CNV model, suggesting a highly
conserved phenomenon across species. Given the increasing
expression of SPP1 in human microglia with age (Sankowski
et al., 2019), the SPP1 signaling pathway in MG may modulate
CNV development in patients with neovascular AMD and
therefore represent a therapeutic target in the future.
Taken together, this study shows that Spp1 is significantly
expressed at RNA and protein level in murine and human
CNV. The intravitreal application of anti-SPP1 antibodies led to
increased CNV lesion size suggesting an anti-angiogenic effect
of SPP1. Our results provide new insights into the biology of
retinal microglia during health and CNV formation and open




In this study, C57BL/6J mice were used as wildtype (WT)
mice. All transgenic lines [Cx3cr1GFP/+, Cx3cr1CreERT2, and
Rosa26-fl-stop-fl-tdTomato (Rosa26-tdTomato)] were bred on a
C57BL/6J background under specific pathogen-free conditions
and devoid of Crb1 (RD8) mutations. Cx3cr1CreERT2 were crossed
to Rosa26-tdTomato. All animal experiments were approved by
local administration and were performed in accordance with the
respective national, federal, and institutional regulations.
Tamoxifen Treatment
For induction of the nuclear CreER-T2 recombinase activity in
adult animals, 6–8-week-old Cx3cr1CreER mice were treated with
4mg Tamoxifen (TAM, T5648-1G, Sigma-Aldrich, Taufkirchen,
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Germany) dissolved in 200 µl corn oil (Sigma-Aldrich, C8267-




Mice were anesthetized with a mixture of ketamine (100
mg/kg) and xylazine (6 mg/kg), and pupils were dilated with a
combination of 0.5% tropicamide and neosynephrine-POS 5%.
Corneal gel was applied to maintain hydration of the cornea
and reduce media opacifications. Mice were placed in front of
an argon laser (VISULAS 532s, ZEISS) after the pupils were
completely dilated. A cover slip with a drop of gel was placed
on the eye as a contact lens to convert the curved cornea into
a planar surface. Three laser burns at equal distance from the
optic disc were induced by an Argon laser with a wavelength
of 532 nm, a power of 150 mW, a fixed diameter of 100µm,
and duration of 100ms. Only burns that produced a bubble as
a sign for retinal pigment epithelial rupture were included in
the study. For immunohistochemical analyses, three laser burns
were applied per eye. For molecular analyses (RNA sequencing
and ELISA) six laser burns were applied per eye to maximize
the enrichment with diseased tissue. Prior to tissue processing,
the peripheral part of the retina (RNA sequencing) or choroid
(ELISA) was removed with small scissors to use only the central
part of the respective tissue (containing the laser lesions) for
analyses. Control eyes without laser treatment were dissected in
the same way. After laser treatment, mice were then placed on
a pre-warmed warming plate at 35◦C until they had recovered
from anesthesia.
Antibody Treatment During Laser-Induced
Choroidal Neovascularization
Choroidal neovascularization was laser-induced at day 0 (d0)
in Cx3cr1GFP/+ mice, as described above, with the following
variations (Tobe et al., 1998). At d1 mice received an intravitreal
injection of 50 ng anti-SPP1 (R&D Systems, AF808) solved
in 1 µL PBS in one eye, whereas the same amount of IgG
control antibody was injected in the same PBS volume in the
contralateral eye (Nanofil Syringe 10 µl equipped with Nanofil
34G needle, World Precision Tools, Sarasota, USA). Mice were
sacrificed at d7 after performing fundus imaging and fluorescence
angiography (Fluorescein (ALCON 10%, H12588-0113) was
diluted 1: 20 with 0.9% NaCl and 40 µL per 20 g mouse were
injected). After enucleation, eye cups were dissected to perform
a collagen IV staining for the evaluation of the lesion size in
the flat-mounts. Animals with subretinal bleedings or confluent
lesions were excluded from further analysis. Lesion area was
normalized to the size in IgG control. Normality was given
using the Kolmogorov-Smirnov-Test and a ratio paired t-test
was applied.
Fluorescence Microscopy
After transcardial perfusion with phosphate-buffered saline
(PBS), eyes were fixed in 4% PFA for 1 h at RT and
processed, as previously described, for flatmounts (Pitulescu
et al., 2010). Primary antibodies goat anti-mouse Collagen IV
(Merck Millipore, MAB769, Burlington, USA) and rabbit anti-
mouse SPP1 (LifeSpan Biosciences, LSBio, LS-B10122, Inc.,
Seattle, USA) were added overnight in a 1:500 (Collagen IV) or
1:1,000 (SPP1) dilution at 4◦C (flatmount). Secondary antibody
was applied in a dilution of 1:500 (Alexa Flour R© 488 and Alexa
Fluor R© 647, Thermo Fisher Scientific, Waltham, USA) overnight
at 4◦C (flatmount). Images were taken using a conventional
fluorescence microscope (Olympus BX-61 with a color camera
[Olympus DP71]) (Olympus, Tokyo, Japan) and the confocal
pictures were taken with a DMi-8 (Leica) with a 20x NA 0.75 CS2
(Leica 506517).
Protein Analysis
Proteins were isolated from choroidal tissue using RIPA buffer
(R0278, Sigma) containing protease (Complete Tablets Mini,
0463159001, Roche) and phosphatase inhibitors (Phosstop,
04906845001, Roche). The amount of recovered protein was
evaluated by colorimetric assay (BCA kit; Pierce, Rockford, IL).
Content of SPP1 (Osteopontin) in 1.25µg of purified protein was
analyzed by using an Osteopontin Mouse ELISA Kit (Thermo
Fisher Scientific) according to the manufacturer’s instructions.
RNA Sequencing and Analysis
Cx3cr1GFP/+ mice were analyzed at the age of 8 weeks. For
isolation of microglia, cells were stained with antibodies
against CD45 (30-F11, 103133, BioLegend, San Diego, CA,
USA), CD11b (M1/70, 17-0112-83, eBioscience, Thermo
Fisher Scientific), Ly6C (AL-21, 45-5932-82, eBioscience,
Thermo Fisher), and Ly6G (1A8, 551460, BD Pharmingen, BD
Biosciences). FVD780 (eBioscience) was used to exclude dead
cells. Total bulk RNA was extracted directly into RNAprotect
buffer (QIAGEN, Hilden, Germany) from viable FACS-sorted
CD45loCD11b+CX3CR1+Ly6C−Ly6G− retinal microglia
according to the “Purification of total RNA from animal and
human cells” protocol of the RNeasy Plus Micro Kit (QIAGEN).
In brief, cells were stored and shipped in RNAprotect buffer at
2–8◦C. After pelleting, the RNAprotect buffer was replaced by
RLT Plus buffer (QIAGEN) and the samples were homogenized
by vortexing for 30 s. Genomic DNA contamination was
removed using gDNA Eliminator spin columns. Next, ethanol
was added and the samples were applied to RNeasy MinElute
spin columns followed by several wash steps. Finally, total RNA
was eluted in 12 µl of nuclease free water. Purity and integrity
of the RNA was assessed on the Agilent 2100 Bioanalyzer
with the RNA 6000 Pico LabChip reagent set (Agilent, Palo
Alto, CA, USA).
The SMARTer Ultra Low Input RNA Kit for Sequencing
v4 (Clontech Laboratories, Inc., Mountain View, CA, USA)
was used to generate first strand cDNA from 150 to 600 pg
total-RNA. Double-stranded cDNA was amplified by LD PCR
(12–14 cycles) and purified via magnetic bead clean-up. Library
preparation was carried out, as described in the Illumina Nextera
XT Sample Preparation Guide (Illumina, Inc., San Diego, CA,
USA). Then, 150 pg of input cDNA were tagmented (tagged
and fragmented) by the Nextera XT transposome. The products
were purified and amplified via a limited-cycle PCR program to
generate multiplexed sequencing libraries. For the PCR step 1:5
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dilutions of index 1 (i7) and index 2 (i5) primers were used. The
libraries were quantified using the KAPA SYBR FAST ABI Prism
Library Quantification Kit (Kapa Biosystems, Inc., Woburn,
MA, USA). Equimolar amounts of each library were pooled,
and the pools were used for cluster generation on the cBot with
the Illumina TruSeq SR Cluster Kit v3. The sequencing run was
performed on an HiSeq 1000 instrument using the indexed, 50
cycles single-read (SR) protocol and the TruSeq SBS v3 Reagents
according to the Illumina HiSeq 1000 System User Guide.
Image analysis and base calling resulted in.bcl files, which were
converted into.fastq files with the bcl2fastq v2.18 software. RNA
extraction, library preparation and RNA-seq were performed
at the Genomics Core Facility “KFB—Center of Excellence
for Fluorescent Bioanalytics” (University of Regensburg,
Regensburg, Germany).
Sequencing data were uploaded to and analyzed on the
Galaxy web platform (usegalaxy.eu) (Afgan et al., 2018), as
previously described (Boneva et al., 2020). Quality control
was performed with FastQC Galaxy Version 0.72 (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/ last access
on 07/30/2020). Reads were mapped to the mouse reference
genome [Gencode (Frankish et al., 2019), version M25] with
RNA STAR (Dobin et al., 2013) Galaxy Version 2.7.2b (default
parameters) using the Gencode main annotation file [Gencod
(Frankish et al., 2019), version M25]. Two BAM files for each
sample (one for each flow cell) were combined in one BAM
file per sample using Merge BAM files Galaxy Version 1.2.0.
Reads mapped to the mouse reference genome were counted by
featureCounts Galaxy Version 1.6.4 (Liao et al., 2014) (default
parameters) using the aforementioned annotation file. The
output of featureCounts was imported into R Studio (Version
1.2.1335, R Version 3.5.3). Gene symbols were determined based
on ENSEMBL (Yates et al., 2020) release 100 (Mouse genes,
download at 08/01/2020). Genes with 0 reads in all samples
were removed from the analysis. After principal component
analysis (Love et al., 2014), differential gene expression was
analyzed using the R package DESeq2 Version 1.22.2 (default
parameters) (Love et al., 2014). Transcripts with log2fold change
(log2FC) > 1.5 or < −1.5 and Benjamini-Hochberg adjusted
p < 0.05 were considered as differentially expressed genes
(DEG). Gene enrichment analysis was performed using the R
package clusterProfiler 3.10.1 (Yu et al., 2012). Heatmaps were
created using the R package ComplexHeatmap 1.20.0 (Gu et al.,
2016). Other data visualization was performed using the ggplot2
package (Wickham, 2009). The sequencing data are available
in the Gene Expression Omnibus Database under the accession
number GSE160011.
RNA Sequencing Using Massive Analysis
of cDNA Ends (MACE)
Total RNA was isolated from formalin-fixed and paraffin-
embedded (FFPE) sections of all specimens using the Quick-
RNA FFPE Kit (Zymo Research, USA). Following a DNAse I
digestion using the Baseline-ZERO kit (Epicenter, USA), the
RNA concentration was measured with the Qubit RNA HS
Assay Kit on a Qubit Fluorometer (Life Technologies, USA).
The RNA quality was determined with the RNA Pico Sensitivity
Assay on a LabChip GXII Touch (PerkinElmer, USA). The
fragment size of all RNA samples ranged between 120 and 150
bp. The preparation of massive analysis of cDNA ends (MACE)
libraries was carried out using 1 µg of total RNA, as previously
described (Zajac et al., 2015). The barcoded libraries (four
CNV membranes and four control samples) were sequenced
simultaneously on the NextSeq 500 (Illumina, USA) with 1 ×
75 bp. Data analysis was conducted as described above with
the following modifications: Reads were mapped to the human
reference genome (hg38, Galaxy built-in reference genome) with
RNA STAR Galaxy Version 2.6.0b-2 6 (default parameters)
using the Gencode annotation file (Gencode 31, release June
2019, downloaded on 08/05/2019, https://www.gencodegenes.
org/human/releases.html). The sequencing data are available in
the Gene Expression Omnibus Database under the accession
number GSE146887.
Human Tissue
Whole human eyes (ciliary body melanoma) or eye tissue
(CNV membrane) were acquired after an informed consent
form was signed by the patients prior to surgery at the Eye
Center, University Medical Center Freiburg. At the Institute
of Anatomy, eyes were enucleated in consent with the body
donors, secured by contract, and no data other than age, sex,
and cause of death were disclosed. MACE RNA Sequencing
was performed on four FFPE-treated CNVmembranes extracted
from patients with neovascular AMD during vitreoretinal
surgery between 1992 and 1999. Four age-matched FFPE RPE-
choroidal specimens were obtained from the macular region
of enucleated eyes suffering from ciliary body melanoma
serving as controls. The macular RPE and choroid was
unaffected in these eyes as confirmed by routine histology.
FFPE tissue was sliced with 7µm thickness and placed on glass
slides. For immunofluorescence, deparaffinization (15min xylol
followed by descending ethanol concentrations with 5min per
concentration [100, 96, and 70%]) was conducted, followed
by adding aqua dest at room temperature and citrate buffer
(pH = 6) for 2 × 5min at 95◦C. After washing 3 ×
10min with PBS TritonX 0.3% (PBS-T), blocking solution
(PBS-T, 5% goat serum) was applied for 30min at RT.
Primary antibodies (IBA1, 234 013, Synaptic Systems; mouse-
anti human SPP1/Osteopontin, LS-C169155, clone 7C5H12,
LifeSpan BioSciences, Inc., Seattle, USA) were diluted in PBS
0.5% bovine serum albumine (BSA) for incubation overnight
at 4◦C. After washing with PBS-T, slides were incubated
with secondary antibodies goat anti-mouse Alexa Fluor R© 647
and goat anti-rabbit Alexa Fluor R© 568 for 1 h at RT. After
washing with aqua dest, autofluorescence was quenched with
Sudan Black B (0.3% in 70% ethanol overnight stirring at
50◦C, filtrated twice and incubated for 5min at 37◦C on the
slides) and nuclei were counterstained with 4′,6-Diamidin-2-
phenylindol (DAPI) 1:10,000 for 10min, washed three times with
aqua dest, and embedded in Fluorescence Mounting Medium
(Agilent Dako).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 January 2021 | Volume 8 | Article 618598
Schlecht et al. Spp1 Expression in Choroidal Neovascularization
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad Software, Version 6.0, La Jolla, USA). Data
were tested for normality applying the Kolmogorov–
Smirnov test. If normality was given, an unpaired t-test
was applied, if not indicated otherwise. If the data did not
meet the criteria of normality, the Mann–Whitney test
was applied. Differences were considered significant when
P < 0.05.
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